Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare is well-positioned to achieve growth and favorable margins due to its dominance in the in-home care services market and potential M&A opportunities. The unpredictability of potential Medicaid funding reforms and persisting labor constraints in clinical businesses may pose risks, but the company has shown strong financials with a 6.5% organic growth rate in its Personal Care segment.

Bears say

Addus HomeCare is unsustainable as they face decreasing revenues in all segments, with a decrease of ~1% and 6.6% in hospice and home health revenue respectively, on a Q/Q and Y/Y basis. This is despite initiatives such as the caregiver app and next-generation Homecare Homebase, and we anticipate further struggles as the company implements these changes and potential multiple compression hampering price. Additionally, the recent first quarter financials fell below projections, further indicating potential struggles ahead for the company.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $132.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $132.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.